Go Deep
Alkem Laboratories Limited
Alkem Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 22,283 | 29.6 | 4.61 | 0.14 | 5,331.50 |
| Sep 2026 | 22,133 | 30.1 | 4.69 | 0.14 | 5,424.00 |
| Sep 2026 | 22,536 | 28.7 | 4.48 | 0.14 | 5,175.00 |
| Sep 2026 | 22,536 | 28.7 | 4.48 | 0.14 | 5,175.00 |
| Sep 2026 | 22,536 | 28.7 | 4.48 | 0.14 | 5,175.00 |
| Sep 2026 | 22,535 | 29.2 | 4.48 | 0.14 | 5,175.00 |
| Oct 2026 | 21,706 | 28.9 | 4.52 | 0.14 | 5,220.00 |
| Oct 2026 | 21,013 | 29.3 | 4.57 | 0.14 | 5,279.00 |
Alkem Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 37,401,500,000.0 | 36,033,200,000.0 | 37,368,200,000.0 | 40,009,900,000.0 |
| Net Profit | 5,199,600,000.0 | 2,364,600,000.0 | 6,360,200,000.0 | 7,650,600,000.0 |
| EPS | 43.5 | 19.8 | 53.2 | 64.0 |
Alkem Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 145,323,400,000.0 | 128,046,200,000.0 | 124,392,400,000.0 | 114,403,500,000.0 | — |
| Net Profit | 23,018,000,000.0 | 21,654,800,000.0 | 17,957,700,000.0 | 9,841,700,000.0 | — |
| EPS | 192.5 | 181.1 | 150.2 | 82.3 | — |
Alkem Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 208,729,700,000.0 | 176,911,000,000.0 | 155,749,000,000.0 | 137,566,500,000.0 | — |
| Total Liabilities | 65,240,400,000.0 | 52,574,700,000.0 | 48,605,000,000.0 | 43,216,500,000.0 | — |
| Total Equity | 138,201,000,000.0 | 119,848,700,000.0 | 103,120,600,000.0 | 90,452,900,000.0 | — |
Owes vs Owns
Alkem Laboratories Limited owed ₹0.31 for every ₹1 it owned in Mar 2026, about the same as ₹0.31 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.31× | 0.30× | 0.31× | 0.31× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Alkem Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 19.5%Receivables 14.3%Inventory 16.0%Fixed assets (tangible) 16.0%Intangible assets 4.4%Other assets 29.7%
How it's funded — Mar 2026
Short-term debt 5.4%Long-term debt 2.4%Payables 10.8%Other liabilities 12.7%Shareholders' equity 68.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4,065.2 | 3,777.9 | 4,269.7 | 1,143.2 |
| Receivables | 2,979.1 | 2,466.2 | 2,252.8 | 2,132.2 |
| Inventory | 3,333.2 | 2,922.4 | 2,661.2 | 2,607.5 |
| Fixed assets (tangible) | 3,345.6 | 2,931.9 | 2,595.5 | 2,513.6 |
| Intangible assets | 924.3 | 537.7 | 474.3 | 492.6 |
| Long-term investments | 34.8 | 32.4 | 0.0 | 564.6 |
| Other assets | 6,190.7 | 5,022.6 | 3,321.4 | 4,303.1 |
| Liabilities & equity | ||||
| Short-term debt | 1,131.0 | 751.9 | 1,174.0 | 1,307.2 |
| Long-term debt | 492.4 | 310.9 | 40.0 | 0.0 |
| Payables | 2,244.2 | 1,937.3 | 1,748.1 | 1,165.0 |
| Other liabilities | 2,656.4 | 2,257.3 | 1,898.4 | 1,849.5 |
| Shareholders' equity | 14,348.9 | 12,433.6 | 10,714.4 | 9,435.0 |
| Net tangible assets | 12,895.8 | 11,447.2 | 9,837.7 | 8,552.7 |
Alkem Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 19,630,300,000.0 | 19,128,400,000.0 | 19,480,700,000.0 | 16,825,000,000.0 | — |
| Investing Activities | -16,672,100,000.0 | -12,987,600,000.0 | -10,085,000,000.0 | 1,128,400,000.0 | — |
| Financing Activities | -5,034,000,000.0 | -8,109,900,000.0 | -11,450,100,000.0 | -17,608,200,000.0 | — |